TXU-PAP FOR THE TREATMENT OF AIDS

TXU-PAP 用于治疗艾滋病

• 批准号: 2875917
• 负责人: FATIH M UCKUN
• 金额: $ 30.76万
• 依托单位: PARKER HUGHES INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-05-01 至 2002-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2875917
• 关键词: AIDS therapy; HIV infections; antiAIDS agent; antiviral agents; biopsy; clinical research; clinical trial phase I; dosage; drug screening /evaluation; human immunodeficiency virus 1; human subject; human therapy evaluation; immunoconjugates; immunotherapy; monoclonal antibody; pharmacokinetics; plant proteins; provirus; virus load

项目成果

Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus.

TXU（抗 CD7）-美洲商陆抗病毒蛋白在感染人类免疫缺陷病毒的黑猩猩和成年患者中的毒性、生物活性和药代动力学。

• 发表时间: 1999-12
• 作者: Uckun, F M;Bellomy, K;O'Neill, K;Messinger, Y;Johnson, T;Chen, C L
• 通讯作者: Chen, C L